The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

White Papers
This white paper was written as a recap of the AHRMM15 Cost, Quality, and Outcomes (CQO) Summit, held in August of 2015.
White Papers
This paper examines the journey that an organization travels to arrive at an outsource decision and the challenges that it should be alert to
White Papers
The purpose of this paper is to share lessons learned and successes in contract management.
Magazine & Journal Articles
Jim Smoker, CMRP, MPA, CS, York, Pennsylvania